Profile
Roberto Camerini is the founder of Network Italiano per la Bioterapia dei Tumori, which was founded in 2005.
He held the title of Director from 2005 to 2011.
Dr. Camerini's former jobs include Director at SciClone Pharmaceuticals LLC from 2009 to 2011, Director-Clinical Research & Development at Alfa Wassermann SpA from 2015 to 2018, Director-Clinical Research & Development at Alfasigma SpA, Head-Clinical Research at Sigma-Tau Industrie Farmaceutiche Riunite SpA, and Project Leader-Clinical Pharmacology at Merck Serono SpA from 1993 to 1998.
He also briefly held the title of Chief Scientific Officer at Cosmo Pharmaceuticals NV in 2020.
Dr. Camerini received his undergraduate and doctorate degrees from Sapienza University of Rome.
Former positions of Roberto Camerini
Companies | Position | End |
---|---|---|
COSMO PHARMACEUTICALS N.V. | Chief Tech/Sci/R&D Officer | 2020-03-11 |
Alfa Wassermann SpA
Alfa Wassermann SpA Pharmaceuticals: MajorHealth Technology Alfa Wassermann SpA manufactures pharmaceutical products. Its products include drugs for thromboembolic diseases, for the treatment and prophylaxis of deep-vein thrombosis, and for gastroenteric tract pathologies. The company was founded by Marino Golinelli on January 24, 1948 and is headquartered in Bologna, Italy. | Chief Tech/Sci/R&D Officer | 2017-12-31 |
Alfasigma SpA
Alfasigma SpA Pharmaceuticals: MajorHealth Technology Alfasigma SpA operates as a holding company with interests in companies in the pharmaceutical industries. The company was founded on May 14, 2015 and is headquartered in Bologna, Italy. | Chief Tech/Sci/R&D Officer | 2017-12-31 |
SCICLONE PHARMACEUTICALS, INC. | Director/Board Member | 2011-05-31 |
Network Italiano per la Bioterapia dei Tumori | Founder | 2010-12-31 |
Training of Roberto Camerini
Sapienza University of Rome | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
COSMO PHARMACEUTICALS N.V. | Health Technology |
Private companies | 6 |
---|---|
SciClone Pharmaceuticals LLC
SciClone Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology SciClone Pharmaceuticals LLC was engaged in the development of therapeutic treatment for oncology, infectious diseases, and cardiovascular disorders. It was also offering ZADAXIN for the treatment of hepatitis B, hepatitis C, certain cancers, and used as immune system enhancer, and DC Bead which is used for the novel treatment of liver cancer. The company was founded in 1990 and was headquartered in San Mateo, CA. | Health Technology |
Sigma-Tau Industrie Farmaceutiche Riunite SpA
Sigma-Tau Industrie Farmaceutiche Riunite SpA Pharmaceuticals: MajorHealth Technology Sigma-Tau Industrie Farmaceutiche Riunite SpA engages in the provision of biopharmacological research and technology development services. It offers pharmaceutical products for therapeutic areas, such as cardiology and metabolism, gastroenterology, infectious diseases, urology, rheumatology, osteoporosis, neurology, psychiatry, and oncology. The company was founded by Emilio Cavazza and Claudio Cavazza in 1957 and is headquartered in Rome, Italy. | Health Technology |
Alfa Wassermann SpA
Alfa Wassermann SpA Pharmaceuticals: MajorHealth Technology Alfa Wassermann SpA manufactures pharmaceutical products. Its products include drugs for thromboembolic diseases, for the treatment and prophylaxis of deep-vein thrombosis, and for gastroenteric tract pathologies. The company was founded by Marino Golinelli on January 24, 1948 and is headquartered in Bologna, Italy. | Health Technology |
Merck Serono SpA
Merck Serono SpA Pharmaceuticals: MajorHealth Technology Merck Serono SpA engages in the manufacture and sale of specialty pharmaceuticals. The company is headquartered in Rome, Italy. | Health Technology |
Network Italiano per la Bioterapia dei Tumori | |
Alfasigma SpA
Alfasigma SpA Pharmaceuticals: MajorHealth Technology Alfasigma SpA operates as a holding company with interests in companies in the pharmaceutical industries. The company was founded on May 14, 2015 and is headquartered in Bologna, Italy. | Health Technology |
- Stock Market
- Insiders
- Roberto Camerini